• Immunotherapy in Oncology
  • Conquering the Cancer Care Continuum
  • Volume 5

    Interview with the Innovator Series

    Volume 9

    Dr. Boccia describes the components of the bioT3 platform and its clinical utility in identifying tumor type and actionable targets for therapy.

  • Volume 5

    Interview with the Innovator Series

    Volume 8

    Dr Stephen C. Malamud and Dr Susan K. Boolbol discuss the importance of using a clinically validated test such as the Breast Cancer IndexSM (BCI).

  • Volume 4

    Polycythemia Vera Interviews

    Weighing the value that emerging therapies have for improving outcomes and significantly impacting quality of life against the cost of care is a challenge for all stakeholders involved in managing patients with PV.

  • Volume 7

    Interview with the Innovator Series

    Vol. 7 Part 1: Defining Precision Medicine in Oncology and Multiple Myeloma

    Listen as some of the top academic and community thought leaders in multiple myeloma define what precision medicine means to them.

Featured Articles

Conquering the Cancer Care Continuum

Faculty Perspectives

Faculty Perspective

In spring and summer 2014, internationally renowned physicians, nurses, pharmacists, payers, basic scientists, and other members of the healthcare team involved in the care of patients with solid tumors and hematologic malignancies gathered at the Annual Meeting of the American Society of Clinical Oncology and the 19th Congress of the European Hematology Association.

Read More

Breast Cancer

Colon Cancer

Lung Cancer

Prostate Cancer

Calendar of Events
CME of the Month
Call for Papers
  • Academy of Oncology Nurse Navigators
  • American Health and Drug Benefits
  • Association for Value-Based Cancer Care
  • Core Principle Solutions, Inc.
  • PMO Live
  • Lynx CME
  • Oncology Practice Management
  • The Oncology Nurse
  • The Oncology Pharmacist
  • Urology Practice Management
  • Value Based Cancer Care
  • Value Based Myeloma